Melanocytes are highly specialized dendritic cells that synthesize and store melanin in subcellular organelles called melanosomes, before transfer to keratinocytes. Melanin is a complex pigment that provides colour and photoprotection to the skin, hair and eyes. The process of synthesis of melanin is called melanogenesis and is regulated by various mechanisms and factors such as genetic, environmental and endocrine factors. The knowledge of the pigmentation process is important to understand hypopigmentation disorders such as vitiligo and also to design adequate treatments. In the present work, we review the signalling pathways involved in vitiligo. Finally, current therapies and treatments including topical, oral and phototherapies are discussed and described, emphasizing future therapies based on different pigmentation mechanisms.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971791PMC
http://dx.doi.org/10.4103/ijd.ijd_1067_21DOI Listing

Publication Analysis

Top Keywords

melanogenesis hypopigmentation
4
hypopigmentation case
4
case vitiligo
4
vitiligo melanocytes
4
melanocytes highly
4
highly specialized
4
specialized dendritic
4
dendritic cells
4
cells synthesize
4
synthesize store
4

Similar Publications

Mechanistic Insights into the Stimulatory Effect of Melanogenesis of 4-Methylcoumarin Derivatives in B16F10 Melanoma Cells.

Int J Mol Sci

November 2024

Department of Chemistry and Cosmetics, Jeju Inside Agency and Cosmetic Science Center, Jeju National University, Jeju 63243, Republic of Korea.

Vitiligo is a skin condition characterized by the loss of pigment, resulting in white patches on various parts of the body. It occurs when melanocytes, the cells that are responsible for producing skin pigment, are destroyed or stop functioning. This study aimed to investigate the melanogenic potential of various 4-methylcoumarin (4MC) derivatives, including 6-methoxy-4-methylcoumarin (6M-4MC), 7-methoxy-4-methylcoumarin (7M-4MC), 7-amino-4-methylcoumarin (7A-4MC), 6,7-dihydroxy-4-methylcoumarin (6,7DH-4MC), 7,8-dihydroxy-4-methylcoumarin (7,8DH-4MC), and 6,7-dimethoxy-4-methylcoumarin (6,7DM-4MC), in B16F10 melanoma cells.

View Article and Find Full Text PDF

Vitiligo is characterized by the depletion of melanocytes due to the activation of CD8 T cells. Taurine-upregulated gene 1 (TUG1), a long noncoding RNA, is involved in melanogenesis. This study aimed to explore the role and mechanism of TUG1 in vitiligo.

View Article and Find Full Text PDF

The oculocutaneous albinism II () gene encodes a melanosomal transmembrane protein involved in melanogenesis. Recent genome-wide association studies have identified several single nucleotide polymorphisms within genes that are involved in skin pigmentation. Nevertheless, there have been no attempts to modulate this gene to improve skin discoloration.

View Article and Find Full Text PDF

1-Acetyl-β-Carboline from a Jeju Gotjawal Strain sp. JNUCC 0626 and Its Melanogenic Stimulating Activity in B16F10 Melanoma Cells.

Molecules

September 2024

Department of Beauty and Cosmetology, Jeju Inside Agency and Cosmetic Science Center, Jeju National University, Jeju 63243, Republic of Korea.

The genus is a prolific source of bioactive and structurally diverse secondary metabolites. We isolated a novel strain, sp. JNUCC 0626, from Hwasun Gotjawal on Jeju Island, Korea.

View Article and Find Full Text PDF

The role of aryl hydrocarbon receptor agonists in the treatment of vitiligo.

Arch Dermatol Res

October 2024

Dermatology Service, Veterans Affairs New York Harbor Healthcare System, Brooklyn Campus, Brooklyn, NY, US.

Article Synopsis
  • * Ruxolitinib is the only FDA-approved medication for vitiligo but has serious side effects, highlighting the need for safer alternatives like aryl hydrocarbon receptor (AhR) agonists.
  • * Recent research shows that AhR agonists, particularly tapinarof, promote skin repigmentation and have a better safety profile, but more clinical trials are needed to fully assess their potential in vitiligo treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!